Cover Image
市場調查報告書

頭孢硫脒(Cefathiamidine)的中國市場分析 (2010∼2019年)

Investigation Report on China Cefathiamidine Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 333479
出版日期 內容資訊 英文 35 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
頭孢硫脒(Cefathiamidine)的中國市場分析 (2010∼2019年) Investigation Report on China Cefathiamidine Market, 2010-2019
出版日期: 2015年06月18日 內容資訊: 英文 35 Pages
簡介

頭孢硫脒(Cefathiamidine)在中國2005年認證,其後急速成長。2005年為1億人民幣以下的銷售額,2014年達4億5900萬人民幣,其間的年複合成長率(CAGR) 記錄為18.6%。頭孢硫脒(Cefathiamidine)雖為第一代頭孢菌素,不過,對其抗菌作用 (特別是腸球菌) 大大凌駕其他產品,活用於呼吸系統、肝臟、五官、泌尿道感染、心內膜炎、敗血症,在廣泛的領域。

本報告提供中國的頭孢硫脒(Cefathiamidine)的市場相關分析,整體市場規模和國內價格趨勢,各企業、各投藥形態的市場佔有率,主要製造商簡介,未來性的市場趨勢預測等調查評估。

第1章 頭孢硫脒(Cefathiamidine)的相關概念

  • 症狀
  • 全球市場的銷售情形

第2章 中國的頭孢硫脒(Cefathiamidine)市場概況

  • 中國國內的頭孢硫脒(Cefathiamidine)專利的申請、認證情形
  • 主要製造商
  • 市場規模

第3章 頭孢硫脒(Cefathiamidine)銷售情形分析 (過去5年份)

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售量

第4章 中國的頭孢硫脒(Cefathiamidine)市場:主要廠商的市場佔有率分析 (過去5年份)

  • 市場佔有率 (銷售額為基礎)
  • 市場佔有率 (銷售量為基礎)

第5章 中國的頭孢硫脒(Cefathiamidine)市場:各劑型分析 (過去5年份)

  • 各劑型的市場佔有率 (銷售額為基礎)
  • 各劑型的市場佔有率 (銷售量為基礎)

第6章 頭孢硫脒(Cefathiamidine)的醫院用標準價格

第7章 中國國內的頭孢硫脒(Cefathiamidine)的主要製造商

第8章 中國的頭孢硫脒(Cefathiamidine)市場未來展望 (今後5年份)

  • 市場規模的預測
  • 競爭環境預測

圖表一覽

目錄
Product Code: 1506221

Developed by Guangzhou Baiyunshan Pharmaceutical General Factory, cefathiamidine has been written into the Chinese Pharmacopoeia (2005). Ever since its marketing in 2000, the sales value of cefathiamidine has risen from less than CNY 100 million in 2005 to CNY 459 million in 2014 with CAGR during this period reaching up to 18.6%.

Despite its status as the first generation of cephalosporin, cefathiamidine's antimicrobial effect especially that on enterococcus has surpassed all other similar products. As a mature product in the clinic, cefathiamidine has been widely used for the treatment of respiratory, liver, five senses, urinary tract infections, endocarditis and sepsis.

Manufacturers of cefathiamidine focus on high-end market and emphasize products' ingenuity and outstanding quality. Currently, the cefathiamidine industry shows a high degree of market concentration. We have Guangzhou Baiyunshan Pharmaceutical General Factory, Shandong Luoxin Pharmacy Stock Co., Ltd, Shandong Lukang Pharmaceutical Co., Ltd, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd and Fuan Pharmaceutical (Group) Qingyutang Pharmaceutical Co., Ltd, among which Guangzhou Baiyunshan Pharmaceutical General Factory has the largest market share of 82.33% in 2014 for sales value. As cefathiamidine acts like Methicillin-resistant Staphylococcus aureus (MRSA) and is much safer than traditional drugs for MRSA like vancomycin, norvancomycin, teicoplanin and linezolid, it still has a market potential. The market size of cefathiamidine is expected to keep growing in the next few years in China.

Readers can get at least the following information from this report:

  • market size of cefathiamidine in China
  • market share of different manufacturers of cefathiamidine in China
  • price of cefathiamidine in China
  • major manufacturers of cefathiamidine in China
  • market outlook of cefathiamidine in China

The author suggests the following groups of people purchase this report:

  • manufacturers of antibiotics
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

Table of Contents

1. Related Concepts of Cefathiamidine

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Cefathiamidine in China

  • 2.1. Patent and Approval Status of Cefathiamidine in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Cefathiamidine in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Region
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Cefathiamidine in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Cefathiamidine in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Cefathiamidine in Chinese Hospitals in 2014

  • 6.1. Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd
  • 6.2. Shandong Luoxin Pharmacy Stock Co., Ltd
  • 6.3. Shandong Lukang Pharmaceutical Co., Ltd (Trade Name: Tiangen)
  • 6.4. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd (Trade Name: Xianlisu)
  • 6.5. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory (Trade Name: Xianlisu)
  • 6.6. KonTam Pharmaceuticals (Zhongshan) Co., Ltd
  • 6.7. Hainan Linoco Pharmaceutical Co., Ltd
  • 6.8. Fuan Pharmaceutical (Group) Qingyutang Pharmaceutical Co., Ltd

7. Major Manufacturers of Cefathiamidine in Chinese Market, 2010-2014

  • 7.1. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory
  • 7.2. Shandong Luoxin Pharmacy Stock Co., Ltd
  • 7.3. Shandong Lukang Pharmaceutical Co., Ltd
  • 7.4. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd
  • 7.5. Fuan Pharmaceutical (Group) Qingyutang Pharmaceutical Co., Ltd

8. Market Outlook of Cefathiamidine in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Selected Charts

  • Chart Approval Information of Cefathiamidine in China
  • Chart Sales Status of Cefathiamidine in China, 2010-2014
  • Chart Sales Value of Cefathiamidine in China,2010-2014
  • Chart Sales Value of Cefathiamidine in Some Regions in China, 2010-2014
  • Chart Sales Volume of Cefathiamidine in China, 2010-2014
  • Chart Sales Volume of Cefathiamidine in Some Regions in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Cefathiamidine for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Cefathiamidine Made by Guangzhou Baiyunshan in China, 2010-2014
  • Chart Sales Value and Market Share of Cefathiamidine Made by Guangzhou Baiyunshan Tianxin in China, 2010-2014
  • Chart Sales Value and Market Share of Cefathiamidine Made by Shandong Luoxin in China, 2010-2014
  • Chart Sales Value and Market Share of Cefathiamidine Made by Lukang Pharmaceutical in China, 2010-2014
  • Chart Sales Value and Market Share of Cefathiamidine Made by Fuan Pharmaceutical (Group) Qingyutang in China, 2010-2014
  • Chart Price of Cefathiamidine Made by Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Cefathiamidine Made by Shandong Luoxin Pharmacy Stock Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Cefathiamidine Made by Shandong Lukang Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Cefathiamidine Made by Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Cefathiamidine Made by Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory in Some Chinese Cities in 2014
  • Chart Price of Cefathiamidine Made by KonTam Pharmaceuticals (Zhongshan) Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Cefathiamidine Made by Hainan Linoco Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Cefathiamidine Made by Fuan Pharmaceutical (Group) Qingyutang Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Back to Top